
chanakon laorob
CytomX Therapeutics (CTMX) announced it will receive a $5 million payment after reaching a preclinical milestone in its cancer drug development partnership with Regeneron (REGN). CytomX shares rose 4.6% in extended trading Wednesday.
The payment provides CytomX (CTMX) with
